BRPI0411225A - derivados de indolila bicìclicos e métodos para seu uso como agentes serotonérgicos - Google Patents

derivados de indolila bicìclicos e métodos para seu uso como agentes serotonérgicos

Info

Publication number
BRPI0411225A
BRPI0411225A BRPI0411225-3A BRPI0411225A BRPI0411225A BR PI0411225 A BRPI0411225 A BR PI0411225A BR PI0411225 A BRPI0411225 A BR PI0411225A BR PI0411225 A BRPI0411225 A BR PI0411225A
Authority
BR
Brazil
Prior art keywords
methods
bicyclic
serotonergic agents
indolyl derivatives
derivatives
Prior art date
Application number
BRPI0411225-3A
Other languages
English (en)
Inventor
Michael Gerard Kelly
Wayne Everett Childers
Boyd Lynn Harrison
Gan Zhang
Byron Abel Bravo
Lee E Schechter
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BRPI0411225A publication Critical patent/BRPI0411225A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"DERIVADOS DE INDOLILA BICìCLICOS E MéTODOS PARA SEU USO COMO AGENTES SEROTONéRGICOS". A presente invenção refere-se a derivados de indolila bicíclicos e composições que contêm tais compostos. São descritos também métodos para usar os derivados de indolila bicíclicos e as composições que contêm tais compostos, como agentes serotonérgicos, tal como no tratamento de depressão e ansiedade. Além disso, são descritos processos para a preparação de derivados de indolila bicíclicos.
BRPI0411225-3A 2003-06-11 2004-06-10 derivados de indolila bicìclicos e métodos para seu uso como agentes serotonérgicos BRPI0411225A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47757503P 2003-06-11 2003-06-11
US10/864,698 US7179813B2 (en) 2003-06-11 2004-06-09 Bicyclic indolyl derivatives and methods for their use as serotonergic agents
PCT/US2004/018472 WO2004111035A1 (en) 2003-06-11 2004-06-10 Bicyclic indolyl derivatives and methods of their use as serotonergic agents

Publications (1)

Publication Number Publication Date
BRPI0411225A true BRPI0411225A (pt) 2006-07-18

Family

ID=33555467

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0411225-3A BRPI0411225A (pt) 2003-06-11 2004-06-10 derivados de indolila bicìclicos e métodos para seu uso como agentes serotonérgicos

Country Status (8)

Country Link
US (2) US7179813B2 (pt)
EP (1) EP1644355A1 (pt)
JP (1) JP2007500751A (pt)
AU (1) AU2004247715A1 (pt)
BR (1) BRPI0411225A (pt)
CA (1) CA2526048A1 (pt)
MX (1) MXPA05013368A (pt)
WO (1) WO2004111035A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7179813B2 (en) * 2003-06-11 2007-02-20 Wyeth Bicyclic indolyl derivatives and methods for their use as serotonergic agents
US9192443B2 (en) 2012-02-06 2015-11-24 Hyprotek, Inc. Combined cap applicators

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ231631A (en) 1988-12-08 1992-07-28 Duphar Int Res Heterocyclically-substituted piperazine and diazepine derivatives and anxiolytic compositions
IL94151A (en) 1989-04-22 1995-08-31 Wyeth John & Brother Ltd History of piperazine, their preparation and pharmaceutical preparations containing them
ATE187718T1 (de) * 1989-04-22 2000-01-15 American Home Prod Tertiäre alkyl funktionalisierte piperazin- derivate
IL101722A (en) 1991-05-02 1996-05-14 Wyeth John & Brother Ltd History of piperazine, their preparation and pharmaceutical preparations containing them
GB9411099D0 (en) * 1994-06-03 1994-07-27 Wyeth John & Brother Ltd Piperazine derivatives
US5486518A (en) 1995-04-10 1996-01-23 American Home Products Corporation 4-indolylpiperazinyl derivatives
US7179813B2 (en) * 2003-06-11 2007-02-20 Wyeth Bicyclic indolyl derivatives and methods for their use as serotonergic agents

Also Published As

Publication number Publication date
MXPA05013368A (es) 2006-03-09
US20070135445A1 (en) 2007-06-14
CA2526048A1 (en) 2004-12-23
AU2004247715A1 (en) 2004-12-23
JP2007500751A (ja) 2007-01-18
US20050124630A1 (en) 2005-06-09
WO2004111035A1 (en) 2004-12-23
EP1644355A1 (en) 2006-04-12
US7179813B2 (en) 2007-02-20

Similar Documents

Publication Publication Date Title
CL2004000647A1 (es) Compuestos derivados de heterociclicos de sulfonamida que contienen fluoro y trifluoro alquilo; composicion farmaceutica; kit farmaceutico; procedimiento de preparacion; y su uso como inhibidores de beta amiloides para tratar alzheimer, angiopatia am
ATE365740T1 (de) Substituierte pyrazolopyrimidine
ATE469892T1 (de) Substituierte 1h-dihydropyrazole, ihre herstellung und verwendung
UY27368A1 (es) Nuevos compuestos
SE0202133D0 (sv) Novel compounds
BRPI0509369A (pt) azaindóis úteis como inibidores de jak e outras proteìna cinases
ATE433447T1 (de) Pyrimiidinverbindungen
ECSP045253A (es) Derivados de 5-feniltiazol y uso como inhibidores de pi3 cinasa
AR011116A1 (es) Compuesto derivado de n-hidroxi-beta-sulfonil propionamida y composicion farmaceutica que lo contiene
DOP2006000169A (es) Inhibidores espiropiperidina de beta-secretasa para el tratamiento de la enfermedad de alzheimer
UY27872A1 (es) Inhibidores de caspasa y usos de los mismos.
BR0313160A (pt) Composto, composição farmacêutica, métodos para tratar uma condição e um neoplasmo suscetìvel em um animal em um animal, processo para preparar um composto e uso de um composto
UY27976A1 (es) Piperazinas heterocíclicas sustituídas para el tratamiento de la esquizofrenia
ES2195785B1 (es) Nuevos derivados de piridazin-3(2h)-ona.
NO20054905L (no) 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika
BR0108679A (pt) Novos compostos
ES2368594T3 (es) Derivados sustituidos de ciclohexilmetilo.
BRPI0606964A2 (pt) pirrolidinas e piperidinas derivadas do acetileno para uso como antagonistas de mglur5
CY1109808T1 (el) Αρυλινδενο-πυριδινες και αρυλινδενο-πυριμιδινες και η χρηση τους ως ανταγωνιστων των υποδοχεων αδενοσινης α2α
BRPI0408353A (pt) composto, composição farmacêutica, métodos para o tratamento de neoplasias suscetìveis e para o tratamento de infecções virais, e, uso de um composto
SG171471A1 (en) New benzimidazole derivatives
SV2004001555A (es) Difenilazetidinonas cationicamente sustituidas, procesos para su preparacion, medicamentos que contienen estos compuestos y sus usos
ATE300541T1 (de) Pyrazolopyridinderivate
SE0403171D0 (sv) New compounds
CL2003002565A1 (es) Compuestos derivados de 3h-quinazolin-4-ona, su proceso de preparacion, composicion farmaceutica que los contiene, y uso en el tratamiento y prevencion de enfermedades mediadas por inhibidores de mao-b, tales como la enfermedad de alzheimer y demenci

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.